UCB launches Eu2bn refi facility

Belgian biopharma group UCB has launched a Eu2bn loan to refinance part of the debt it took on to buy German rival Schwarz Pharma in 2006.

  • 26 Nov 2009

The facility is split into a Eu500m 364 day term loan and a Eu1.5bn three year revolver with an optional one year extension. The deal is being co-ordinated by BNP Paribas Fortis, Commerzbank and Mizuho.

The loan will partly refinance a Eu4bn acquisition facility taken out by UCB ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Citi 4,296 9 12.47
2 BNP Paribas 3,136 11 9.10
3 Bank of America Merrill Lynch (BAML) 2,934 10 8.52
4 Lloyds Bank 2,213 9 6.42
5 Credit Agricole 2,025 6 5.88

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 45,786.98 132 11.43%
2 Bank of America Merrill Lynch 42,772.13 118 10.68%
3 Wells Fargo Securities 33,822.43 98 8.45%
4 JPMorgan 31,322.80 90 7.82%
5 Credit Suisse 24,807.99 61 6.20%